|
Vrsta |
Publikacija |
| 3 |
Časopis |
Trissel LA, Martinez JF.
Compatibility of amifostine with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1995 ; 52: 2208-2212. |
| 155 |
Časopis |
Trissel LA, Martinez JF, Xu QA.
Incompatibility of fluorouracil with leucovorin calcium or levoleucovorin calcium.
Am J Health-Syst Pharm 1995 ; 52: 710-715. |
| 1520 |
Laboratorija |
Etude de stabilité des médicaments en Ecoflac®
B Braun 2001 |
| 1914 |
Laboratorija |
Pemetrexed (Alimta®) - Summary of Product Characteristics
Eli Lilly 2016 |
| 2130 |
Časopis |
Lokiec F, Amirault P, Bonnans H, Gauzan MF, Sauvage N, Santoni J.
Stabilité du mélange 5-fluoro-uracil-acide fonique : influence des concentrations, du contenant et de la forme de l’acide folinique.
Bull Cancer 1999 ; 86, 11: 946-954. |
| 2181 |
Časopis |
Milano G, Renée N.
Etude de compatibilité physicochimique 5- fluoro-uracile (nouvelle préparation française) - acide folinique.
Bull Cancer 1995 ; 82: 189-195. |
| 2295 |
Laboratorija |
Fosaprepitant (Emend®) - Summary of Product Characteristics
Merck Sharp Dohme 2013 |
| 2361 |
Časopis |
Lebitasy M, Hecq J.D, Athanassopoulos A, Vanbeckbergen D, Jamart J, Galanti L.
Effect of freeze-thawing on the long-term stability of calcium levofolinate in 5% dextrose stored on polyolefin infusion bags.
J Clin Pharm Ther 2009 ; 34, 4 : 423-428. |
| 2531 |
Časopis |
Sanogo S, Silimbani P, Gaggeri R, Masini C.
Stability of calcium levofolinate reconstituted in syringes and diluted in NaCl 0.9% and glucose 5% polyolefin/ polyamide infusion bags.
J Oncol Pharm Practice 2021 ; 27, 2: 288-296. |
| 3369 |
Laboratorija |
Levofolinate de sodium Medac - Résumé des caractéristiques du produits
MEDAC France 2011 |
| 3523 |
Laboratorija |
Ceftriaxone (Rocephin®) - Summary of Product Characteristics.
Roche 2018 |
| 3546 |
Laboratorija |
Cefamandole Flavelab - Résumé des caractéristiques du produit
Panpharma SA 2007 |
| 3619 |
Laboratorija |
Pamidronate (Pamidronate Actavis®) - Summary of Product Characteristics
Wockhardt 2016 |
| 3621 |
Laboratorija |
Phosphate dipotassique - Résumé des caractéristiques du produit
Renaudin 2008 |
| 3662 |
Laboratorija |
Foscavir (Foscarnet®) - Summary of Product Characteristics
Clinigen 2014 |
| 3753 |
Laboratorija |
Tedizolid phosphate (Sivextro®) - Summary of Product Characteristics
Cubist Pharmaceuticals 2014 |
| 3838 |
Laboratorija |
Magnesium Sulphate - Summary of Product Characteristics
Martindale Pharmaceuticals Ltd 2007 |
| 3933 |
Laboratorija |
Acide zolédronique - (Acide zoledronique Teva Pharma) - Résumé des caractéristiques du produit
Teva Laboratoire 2015 |
| 4154 |
Laboratorija |
Bleomycin sulfate- Summary of Product Characteristics
Accord Health Care 2018 |
| 4720 |
Laboratorija |
Nuzyra (amadacycline - Full prescribing infomation. Paratek Pharmaceuticals updated May 2021.
Paratek Pharmaceuticals 2021 |
